Hemab Therapeutics Holdings, Inc. (COAG)
NASDAQ: COAG · Real-Time Price · USD
41.45
+1.03 (2.55%)
Oct 30, 2026, 4:00 PM EST - Market closed
COAG Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, COAG stock has a consensus rating of "Strong Buy" and an average price target of $62.67. The average 1-year stock price forecast is 51.19% higher than the current stock price, while the lowest is $58 (+39.93%) and the highest is $70 (+68.88%).
Price Target: $62.67 (+51.19%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for COAG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Initiates $70 | Buy | Initiates | $70 | +68.88% | Oct 16, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $56 | Buy | Initiates | $56 | +35.10% | Oct 12, 2026 |
| Wedbush | Wedbush | Buy Maintains $55 → $64 | Buy | Maintains | $55 → $64 | +54.40% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $52 → $60 | Buy | Reiterates | $52 → $60 | +44.75% | Aug 11, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $36 → $46 | Buy | Maintains | $36 → $46 | +10.98% | Jul 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.11
EPS Next Year
-2.55
from -3.11
EPS and Forward PE are based on non-GAAP adjusted numbers.